Northwest Clinical Research Center

Improving Lives Through Research

Contact Us

425.453.0404

US FDA Approved Pediatric Trials

Northwest Clinical Research Center offers a variety of Pediatric studies evaluating potential medication that has been approved for investigation by the US FDA (Food and Drug Administration).

If you are interested in participating in a clinical research study, you can schedule a no cost, in-person evaluation to meet with our doctors and see if our studies are the right fit for you.

To participate in a clinical trial, please give us a call to schedule at 425-453-0404.

For specific details of our ongoing trials, please see the links below, provided by the National Library of Medicine:

 

Pediatric Studies

BHV3000-311: Phase 3, multicenter, randomized, double-blind, group sequential,placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in children and adolescents greater than or equal to 6 and <18 years of age. NCT04743141

TRIAL DETAILS

ITI-007-321: An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone in the Treatment of Pediatric Patients with Schizophrenia, Bipolar Disorder, or Autism Spectrum Disorder

NCT06229210

TRIAL DETAILS

ITI-007-601: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated with Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

NCT06690398

TRIAL DETAILS

ITI-007-421: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lumateperone for the Treatment of Major Depressive Episodes (MDEs) Associated with Bipolar I or Bipolar II disorder (Bipolar Depression) in Pediatric Patients Aged 10 to 17 Years

NCT06372964

TRIAL DETAILS

Study Evaluation Process

  • Screening: Determine eligibility and safety through medical examinations, questionnaires, and interviews.
  • Informed Consent: Receive detailed information about the trial, including risks and benefits.
  • Treatment: Receive investigational medication and placebo, and follow the trail protocol regarding current treatments and medications.
  • Monitoring: Close monitoring of conditions and side effects through check-ups, laboratory tests, EKG’s and assessments.

NWCRC in Bellevue, WA. Research and medical studies patient lounge.

CONTACT US

To be contacted about this study, fill out the contact form or call 425-453-0404.

This field is for validation purposes and should be left unchanged.
We complete all visits in person. Do you live within 50 miles of Bellevue, WA?(Required)


Are you interested in participating in clinical trials?(Required)


Please indicated which study you are interested in.(Required)